{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:05:26Z","timestamp":1789873526158,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Nimodipine (ND) is a vasodilator drug that is used for acute subarachnoid\nhemorrhage. It has a predominant hydrophobic property, causing low solubility and low bioavailability.\nSpanlastics are elastic nanovesicular systems based on non-ionic surfactants and edge activators\nas major components. The goal of this work is to formulate ND as spanlastic nanovesicles to\nimprove the drug's bioavailability.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Spanlastic formulations containing ND were prepared by using the ethanol injection\nmethod. The composition of the ND formulation includes Span60 as a nonionic surfactant and\nTween 20 as edge activators in different ratios. Stabilizers like Soluplus (SP) are used in some formulations\nand then compared with other formulations without that stabilizer. The evaluation study\ninvolved Vesicle Size (VS), PolyDispersity Index (PDI), and Entrapment Efficiency (%EE). Then,\nthe optimized formula was subjected to an in vitro release study and zeta potential, additionally\ncomparing the optimized formula with the formula without soluplus in the same concentration in\nScanning Electron Microscopy (SEM), solubility study, Deformability Index (DI), and stability\nstudy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results indicated a significant shift in some evaluation criteria and a non-significant\nchange in other characterizations, including the difference in polymer ratio, sonication time (ST),\nand the existence of a stabilizer. The best formula, F27, was found to have VS, PDI, %EE, and zeta\npotential of 125.7\u00b10.29 nm, 0.4744\u00b10.002, and 85.43\u00b10.17% and -20.01 \u00b1 0.89 mV, respectively.\nThe photomicrographs of the prepared spanlastic revealed a more uniform and spherical spanlastic,\nindicating a greater capacity for continuous release. With the addition of Soluplus, the formula became\nmore stable in one month and had a higher deformability index.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Discussion:<\/jats:title>\n<jats:p>A significant shift was observed in both VS and PDI. As the stabilizer concentration\nincreases, VS and PDI will decrease. The non-significant shift was noted in the %EE with the presence\nof a stabilizer. Soluplus has the ability to spontaneously self-assemble into spherical particles.\nAdditionally, PEG 6000, as a component of Soluplus's structure, has a tendency to form strong or\ntightly bound bilayers and prevent aggregation and formulation of large vesicles.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study explains the accessibility of the formulation of ND as spanlastic nanovesicles\nby using the ethanol injection method. This spanlastic formulation contains non-ionic surfactants\nand edge activators (Span 40 and Tween 20) in varying ratios. To get a stable formula, Soluplus\nis added to prevent the development of crystals and agglomeration.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0122117385348551241028102256","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T09:46:58Z","timestamp":1731059218000},"page":"551-563","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Soluplus-Stabilized Nimodipine-Entrapped Spanlastic Formulations Prepared with Edge Activator (Tween20): Comparative Physicochemical Evaluation"],"prefix":"10.2174","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-6737","authenticated-orcid":true,"given":"Hussein K.","family":"Alkufi","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, University of Thi-Qar, Nasiriyah, 64001, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-339X","authenticated-orcid":true,"given":"Hanan J.","family":"Kassab","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122117385348551241028102256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/236058\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0122117385348551241028102256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T06:32:32Z","timestamp":1747895552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/236058\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0122117385348551241028102256","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}